SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 274 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $494,000 | +19.9% | 19,646 | -0.6% | 0.01% | 0.0% |
Q3 2020 | $412,000 | -12.0% | 19,758 | +0.2% | 0.01% | -20.0% |
Q2 2020 | $468,000 | +42.2% | 19,725 | +7.9% | 0.01% | +25.0% |
Q1 2020 | $329,000 | -24.0% | 18,273 | 0.0% | 0.01% | 0.0% |
Q4 2019 | $433,000 | -11.5% | 18,273 | +2.6% | 0.01% | -20.0% |
Q3 2019 | $489,000 | -15.5% | 17,809 | +1.8% | 0.01% | -16.7% |
Q2 2019 | $579,000 | -1.7% | 17,486 | +4.1% | 0.01% | 0.0% |
Q1 2019 | $589,000 | +9.3% | 16,803 | +3.5% | 0.01% | -7.7% |
Q4 2018 | $539,000 | -30.8% | 16,228 | +4.9% | 0.01% | -18.8% |
Q3 2018 | $779,000 | -13.0% | 15,471 | +3.4% | 0.02% | -20.0% |
Q2 2018 | $895,000 | +36.6% | 14,957 | +4.6% | 0.02% | +33.3% |
Q1 2018 | $655,000 | +23.4% | 14,297 | +7.2% | 0.02% | +25.0% |
Q4 2017 | $531,000 | +3.3% | 13,333 | +3.8% | 0.01% | -7.7% |
Q3 2017 | $514,000 | -3.7% | 12,840 | +3.5% | 0.01% | 0.0% |
Q2 2017 | $534,000 | +45.5% | 12,400 | +5.8% | 0.01% | +44.4% |
Q1 2017 | $367,000 | +34.4% | 11,720 | +8.3% | 0.01% | +28.6% |
Q4 2016 | $273,000 | +8.3% | 10,818 | +6.1% | 0.01% | 0.0% |
Q3 2016 | $252,000 | +82.6% | 10,192 | +50.7% | 0.01% | +75.0% |
Q2 2016 | $138,000 | +48.4% | 6,763 | +11.1% | 0.00% | +33.3% |
Q1 2016 | $93,000 | +25.7% | 6,088 | +10.3% | 0.00% | +50.0% |
Q4 2015 | $74,000 | +5.7% | 5,520 | +10.5% | 0.00% | 0.0% |
Q3 2015 | $70,000 | +4.5% | 4,996 | +26.2% | 0.00% | 0.0% |
Q2 2015 | $67,000 | – | 3,959 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EXCHANGE TRADED CONCEPTS, LLC | 42,189 | $1,220,950 | 0.03% |
MASSMUTUAL TRUST CO FSB/ADV | 320 | $9,261 | 0.00% |
Versant Capital Management, Inc | 16 | $463 | 0.00% |